Advertisement
Screener

Intuitive Surgical, Inc. (ISRG) Share-based Payment Arrangement, Expense, after Tax

2.9 / 5 stars · 51/87 Roast Me

Intuitive Surgical, Inc. Share-based Payment Arrangement, Expense, after Tax

Intuitive Surgical, Inc. (ISRG) reported Share-based Payment Arrangement, Expense, after Tax of $169.80 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-21.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax · last filed 2026-07-21

  • Intuitive Surgical, Inc. share-based payment arrangement, expense, after tax for the quarter ending 2026-06-30 was $169.80M, a 5.73% increase year-over-year.
  • Intuitive Surgical, Inc. share-based payment arrangement, expense, after tax for the quarter ending 2026-03-31 was $170.60M, a 11.72% increase year-over-year.
  • Intuitive Surgical, Inc. share-based payment arrangement, expense, after tax for the quarter ending 2025-12-31 was $164.70M, a 11.74% increase year-over-year.
  • Intuitive Surgical, Inc. share-based payment arrangement, expense, after tax for the quarter ending 2025-09-30 was $163.50M, a 17.71% increase year-over-year.
  • Intuitive Surgical, Inc. share-based payment arrangement, expense, after tax for fiscal 2025 was $641.50M, a 16.68% increase from fiscal 2024.
  • Intuitive Surgical, Inc. share-based payment arrangement, expense, after tax for fiscal 2024 was $549.80M, a 14.35% increase from fiscal 2023.
  • Intuitive Surgical, Inc. share-based payment arrangement, expense, after tax for fiscal 2023 was $480.80M, a 15.91% increase from fiscal 2022.
  • Intuitive Surgical, Inc. share-based payment arrangement, expense, after tax for fiscal 2022 was $414.80M, a 14.24% increase from fiscal 2021.
Period endShare-based Payment Arrangement, Expense, after Tax 3 monthShare-based Payment Arrangement, Expense, after Tax 6 monthShare-based Payment Arrangement, Expense, after Tax 9 monthShare-based Payment Arrangement, Expense, after Tax 12 month
2026-06-30$169.80M
10-Q · filed 2026-07-21
$340.40M
10-Q · filed 2026-07-21
$505.10M
derived: sum of 3 quarters · filed 2026-07-21
$668.60M
derived: sum of 4 quarters · filed 2026-07-21
2026-03-31$170.60M
10-Q · filed 2026-04-22
$335.30M
derived: sum of 2 quarters · filed 2026-04-22
$498.80M
derived: sum of 3 quarters · filed 2026-04-22
$659.40M
derived: sum of 4 quarters · filed 2026-07-21
2025-12-31$164.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03
$328.20M
derived: sum of 2 quarters · filed 2026-02-03
$488.80M
derived: sum of 3 quarters · filed 2026-07-21
$641.50M
10-K · filed 2026-02-03
2025-09-30$163.50M
10-Q · filed 2025-10-22
$324.10M
derived: sum of 2 quarters · filed 2026-07-21
$476.80M
10-Q · filed 2025-10-22
$624.20M
derived: sum of 4 quarters · filed 2026-07-21
2025-06-30$160.60M
10-Q · filed 2026-07-21
$313.30M
10-Q · filed 2026-07-21
$460.70M
derived: sum of 3 quarters · filed 2026-07-21
$599.60M
derived: sum of 4 quarters · filed 2026-07-21
2025-03-31$152.70M
10-Q · filed 2026-04-22
$300.10M
derived: sum of 2 quarters · filed 2026-04-22
$439.00M
derived: sum of 3 quarters · filed 2026-04-22
$579.30M
derived: sum of 4 quarters · filed 2026-04-22
2024-12-31$147.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03
$286.30M
derived: sum of 2 quarters · filed 2026-02-03
$426.60M
derived: sum of 3 quarters · filed 2026-02-03
$549.80M
10-K · filed 2026-02-03
2024-09-30$138.90M
10-Q · filed 2025-10-22
$279.20M
derived: sum of 2 quarters · filed 2025-10-22
$402.40M
10-Q · filed 2025-10-22
$522.50M
derived: sum of 4 quarters · filed 2026-02-03
2024-06-30$140.30M
10-Q · filed 2025-07-23
$263.50M
10-Q · filed 2025-07-23
$383.60M
derived: sum of 3 quarters · filed 2026-02-03
$512.00M
derived: sum of 4 quarters · filed 2026-02-03
2024-03-31$123.20M
10-Q · filed 2025-04-23
$243.30M
derived: sum of 2 quarters · filed 2026-02-03
$371.70M
derived: sum of 3 quarters · filed 2026-02-03
$491.40M
derived: sum of 4 quarters · filed 2026-02-03
2023-12-31$120.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03
$248.50M
derived: sum of 2 quarters · filed 2026-02-03
$368.20M
derived: sum of 3 quarters · filed 2026-02-03
$480.80M
10-K · filed 2026-02-03
2023-09-30$128.40M
10-Q · filed 2024-10-18
$248.10M
derived: sum of 2 quarters · filed 2024-10-18
$360.70M
10-Q · filed 2024-10-18
$463.20M
derived: sum of 4 quarters · filed 2025-01-31
2023-06-30$119.70M
10-Q · filed 2024-07-19
$232.30M
10-Q · filed 2024-07-19
$334.80M
derived: sum of 3 quarters · filed 2025-01-31
$446.50M
derived: sum of 4 quarters · filed 2025-01-31
2023-03-31$112.60M
10-Q · filed 2024-04-19
$215.10M
derived: sum of 2 quarters · filed 2025-01-31
$326.80M
derived: sum of 3 quarters · filed 2025-01-31
$433.20M
derived: sum of 4 quarters · filed 2025-01-31
2022-12-31$102.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-31
$214.20M
derived: sum of 2 quarters · filed 2025-01-31
$320.60M
derived: sum of 3 quarters · filed 2025-01-31
$414.80M
10-K · filed 2025-01-31
2022-09-30$111.70M
10-Q · filed 2023-10-20
$218.10M
derived: sum of 2 quarters · filed 2023-10-20
$312.30M
10-Q · filed 2023-10-20
$406.10M
derived: sum of 4 quarters · filed 2024-01-31
2022-06-30$106.40M
10-Q · filed 2023-07-24
$200.60M
10-Q · filed 2023-07-24
$294.40M
derived: sum of 3 quarters · filed 2024-01-31
$392.50M
derived: sum of 4 quarters · filed 2024-01-31
2022-03-31$94.20M
10-Q · filed 2023-04-20
$188.00M
derived: sum of 2 quarters · filed 2024-01-31
$286.10M
derived: sum of 3 quarters · filed 2024-01-31
$373.70M
derived: sum of 4 quarters · filed 2024-01-31
2021-12-31$93.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-01-31
$191.90M
derived: sum of 2 quarters · filed 2024-01-31
$279.50M
derived: sum of 3 quarters · filed 2024-01-31
$363.10M
10-K · filed 2024-01-31
2021-09-30$98.10M
10-Q · filed 2022-10-21
$185.70M
derived: sum of 2 quarters · filed 2022-10-21
$269.30M
10-Q · filed 2022-10-21
$353.40M
derived: sum of 4 quarters · filed 2023-02-10
2021-06-30$87.60M
10-Q · filed 2022-07-22
$171.20M
10-Q · filed 2022-07-22
$255.30M
derived: sum of 3 quarters · filed 2023-02-10
$340.00M
derived: sum of 4 quarters · filed 2023-02-10
2021-03-31$83.60M
10-Q · filed 2022-04-22
$167.70M
derived: sum of 2 quarters · filed 2023-02-10
$252.40M
derived: sum of 3 quarters · filed 2023-02-10
$328.80M
derived: sum of 4 quarters · filed 2023-02-10
2020-12-31$84.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10
$168.80M
derived: sum of 2 quarters · filed 2023-02-10
$245.20M
derived: sum of 3 quarters · filed 2023-02-10
$317.30M
10-K · filed 2023-02-10
2020-09-30$84.70M
10-Q · filed 2021-10-20
$161.10M
derived: sum of 2 quarters · filed 2021-10-20
$233.20M
10-Q · filed 2021-10-20
$303.90M
derived: sum of 4 quarters · filed 2022-02-03
2020-06-30$76.40M
10-Q · filed 2021-07-21
$148.70M
10-Q · filed 2021-07-21
$219.20M
derived: sum of 3 quarters · filed 2022-02-03
$290.40M
derived: sum of 4 quarters · filed 2022-02-03
2020-03-31$72.30M
10-Q · filed 2021-04-21
$142.80M
derived: sum of 2 quarters · filed 2022-02-03
$214.00M
derived: sum of 3 quarters · filed 2022-02-03
$279.50M
derived: sum of 4 quarters · filed 2022-02-03
2019-12-31$70.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03
$141.70M
derived: sum of 2 quarters · filed 2022-02-03
$207.20M
derived: sum of 3 quarters · filed 2022-02-03
$267.70M
10-K · filed 2022-02-03
2019-09-30$71.20M
10-Q · filed 2020-10-19
$136.70M
derived: sum of 2 quarters · filed 2020-10-19
$197.20M
10-Q · filed 2020-10-19
$253.30M
derived: sum of 4 quarters · filed 2021-02-10
2019-06-30$65.50M
10-Q · filed 2020-07-23
$126.00M
10-Q · filed 2020-07-23
$182.10M
derived: sum of 3 quarters · filed 2021-02-10
$237.90M
derived: sum of 4 quarters · filed 2021-02-10
2019-03-31$60.50M
10-Q · filed 2020-04-17
$116.60M
derived: sum of 2 quarters · filed 2021-02-10
$172.40M
derived: sum of 3 quarters · filed 2021-02-10
$223.20M
derived: sum of 4 quarters · filed 2021-02-10
2018-12-31$56.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-10
$111.90M
derived: sum of 2 quarters · filed 2021-02-10
$162.70M
derived: sum of 3 quarters · filed 2021-02-10
$208.30M
10-K · filed 2021-02-10
2018-09-30$55.80M
10-Q · filed 2019-10-18
$106.60M
derived: sum of 2 quarters · filed 2019-10-18
$152.20M
10-Q · filed 2019-10-18
$209.10M
derived: sum of 4 quarters · filed 2020-02-07
2018-06-30$50.80M
10-Q · filed 2019-07-22
$96.40M
10-Q · filed 2019-07-22
$153.30M
derived: sum of 3 quarters · filed 2020-02-07
$190.80M
derived: sum of 4 quarters · filed 2020-02-07
2018-03-31$45.60M
10-Q · filed 2019-04-19
$102.50M
derived: sum of 2 quarters · filed 2020-02-07
$140.00M
derived: sum of 3 quarters · filed 2020-02-07
$174.20M
derived: sum of 4 quarters · filed 2020-02-07
2017-12-31$56.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-07
$94.40M
derived: sum of 2 quarters · filed 2020-02-07
$128.60M
derived: sum of 3 quarters · filed 2020-02-07
$160.70M
10-K · filed 2020-02-07
2017-09-30$37.50M
10-Q · filed 2018-10-22
$71.70M
derived: sum of 2 quarters · filed 2018-10-22
$103.80M
10-Q · filed 2018-10-22
$134.80M
derived: sum of 4 quarters · filed 2019-02-04
2017-06-30$34.20M
10-Q · filed 2018-07-20
$66.30M
10-Q · filed 2018-07-20
$97.30M
derived: sum of 3 quarters · filed 2019-02-04
$129.40M
derived: sum of 4 quarters · filed 2019-02-04
2017-03-31$32.10M
10-Q · filed 2018-04-18
$63.10M
derived: sum of 2 quarters · filed 2019-02-04
$95.20M
derived: sum of 3 quarters · filed 2019-02-04
$124.40M
derived: sum of 4 quarters · filed 2019-02-04
2016-12-31$31.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-04
$63.10M
derived: sum of 2 quarters · filed 2019-02-04
$92.30M
derived: sum of 3 quarters · filed 2019-02-04
$121.90M
10-K · filed 2019-02-04
2016-09-30$32.10M
10-Q · filed 2017-10-20
$61.30M
derived: sum of 2 quarters · filed 2017-10-20
$90.90M
10-Q · filed 2017-10-20
$122.10M
derived: sum of 4 quarters · filed 2018-02-02
2016-06-30$29.20M
10-Q · filed 2017-07-21
$58.80M
10-Q · filed 2017-07-21
$90.00M
derived: sum of 3 quarters · filed 2018-02-02
$119.30M
derived: sum of 4 quarters · filed 2018-02-02
2016-03-31$29.60M
10-Q · filed 2017-04-19
$60.80M
derived: sum of 2 quarters · filed 2018-02-02
$90.10M
derived: sum of 3 quarters · filed 2018-02-02
$118.20M
derived: sum of 4 quarters · filed 2018-02-02
2015-12-31$31.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-02
$60.50M
derived: sum of 2 quarters · filed 2018-02-02
$88.60M
derived: sum of 3 quarters · filed 2018-02-02
$116.30M
10-K · filed 2018-02-02
2015-09-30$29.30M
10-Q · filed 2016-10-19
$57.40M
derived: sum of 2 quarters · filed 2016-10-19
$85.10M
10-Q · filed 2016-10-19
$113.90M
derived: sum of 4 quarters · filed 2017-02-06
2015-06-30$28.10M
10-Q · filed 2016-07-20
$55.80M
10-Q · filed 2016-07-20
$84.60M
derived: sum of 3 quarters · filed 2017-02-06
$114.90M
derived: sum of 4 quarters · filed 2017-02-06
2015-03-31$27.70M
10-Q · filed 2016-04-19
$56.50M
derived: sum of 2 quarters · filed 2017-02-06
$86.80M
derived: sum of 3 quarters · filed 2017-02-06
$115.50M
derived: sum of 4 quarters · filed 2017-02-06
2014-12-31$28.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-06
$59.10M
derived: sum of 2 quarters · filed 2017-02-06
$87.80M
derived: sum of 3 quarters · filed 2017-02-06
$115.60M
10-K · filed 2017-02-06
2014-09-30$30.30M
10-Q · filed 2015-10-21
$59.00M
derived: sum of 2 quarters · filed 2015-10-21
$86.80M
10-Q · filed 2015-10-21
$111.00M
derived: sum of 4 quarters · filed 2016-02-02
2014-06-30$28.70M
10-Q · filed 2015-07-22
$56.50M
10-Q · filed 2015-07-22
$80.70M
derived: sum of 3 quarters · filed 2016-02-02
$114.60M
derived: sum of 4 quarters · filed 2016-02-02
2014-03-31$27.80M
10-Q · filed 2015-04-22
$52.00M
derived: sum of 2 quarters · filed 2016-02-02
$85.90M
derived: sum of 3 quarters · filed 2016-02-02
$112.20M
derived: sum of 4 quarters · filed 2016-02-02
2013-12-31$24.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-02
$58.10M
derived: sum of 2 quarters · filed 2016-02-02
$84.40M
derived: sum of 3 quarters · filed 2016-02-02
$110.40M
10-K · filed 2016-02-02
2013-09-30$33.90M
10-Q · filed 2014-10-23
$60.20M
derived: sum of 2 quarters · filed 2014-10-23
$86.20M
10-Q · filed 2014-10-23
$113.00M
derived: sum of 4 quarters · filed 2015-02-06
2013-06-30$26.30M
10-Q · filed 2014-07-24
$52.30M
10-Q · filed 2014-07-24
$79.10M
derived: sum of 3 quarters · filed 2015-02-06
$111.50M
derived: sum of 4 quarters · filed 2015-02-06
2013-03-31$26.00M
10-Q · filed 2014-04-25
$52.80M
derived: sum of 2 quarters · filed 2015-02-06
$85.20M
derived: sum of 3 quarters · filed 2015-02-06
$108.40M
derived: sum of 4 quarters · filed 2015-02-06
2012-12-31$26.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-06
$59.20M
derived: sum of 2 quarters · filed 2015-02-06
$82.40M
derived: sum of 3 quarters · filed 2015-02-06
$105.80M
10-K · filed 2015-02-06
2012-09-30$32.40M
10-Q · filed 2013-10-18
$55.60M
derived: sum of 2 quarters · filed 2013-10-18
$79.00M
10-Q · filed 2013-10-18
$102.80M
derived: sum of 4 quarters · filed 2014-02-03
2012-06-30$23.20M
10-Q · filed 2013-07-22
$46.60M
10-Q · filed 2013-07-22
$70.40M
derived: sum of 3 quarters · filed 2014-02-03
$94.90M
derived: sum of 4 quarters · filed 2014-02-03
2012-03-31$23.40M
10-Q · filed 2013-04-19
$47.20M
derived: sum of 2 quarters · filed 2014-02-03
$71.70M
derived: sum of 3 quarters · filed 2014-02-03
$95.30M
derived: sum of 4 quarters · filed 2014-02-03
2011-12-31$23.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-03
$48.30M
derived: sum of 2 quarters · filed 2014-02-03
$71.90M
derived: sum of 3 quarters · filed 2014-02-03
$93.50M
10-K · filed 2014-02-03
2011-09-30$24.50M
10-Q · filed 2012-10-18
$48.10M
derived: sum of 2 quarters · filed 2012-10-18
$69.70M
10-Q · filed 2012-10-18
2011-06-30$23.60M
10-Q · filed 2012-07-23
$45.20M
10-Q · filed 2012-07-23
2011-03-31$21.60M
10-Q · filed 2012-04-19
2010-12-31$78.40M
10-K · filed 2013-02-04

Similar stocks

Stock NameCountryMarket CapPE Ratio
Edwards Lifesciences Corp (EW)United States$49.409B51.96
STERIS plc (STE)Ireland$20.343B25.49
ZIMMER BIOMET HOLDINGS, INC. (ZBH)United States$17.103B20.66
ALIGN TECHNOLOGY INC (ALGN)United States$10.346B29.06
MSA Safety Inc (MSA)United States$7.023B21.47
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)$1.954B-65.76
Cadre Holdings, Inc. (CDRE)United States$1.123B33.88
Enovis CORP (ENOV)United States$1.053B-1.18
Anteris Technologies Global Corp. (AVR)United States$0.746B
Sanara MedTech Inc. (SMTI)United States$0.323B-6.81